ENDRA Life Sciences (NDRA) Net Cash Flow Growth (3y) (2019 - 2026)
ENDRA Life Sciences (NDRA) Net Cash Flow Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -10.07% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.97% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 144.76% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 41.14% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 29.81% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -26.81% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 14.18% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 4.49% |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | 45.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.69% |
| Dec 31, 2025 | 78.36% |
| Sep 30, 2025 | 32.24% |
| Jun 30, 2025 | -27.28% |
| Mar 31, 2025 | 20.69% |
| Dec 31, 2024 | 13.37% |
| Sep 30, 2024 | 9.72% |
| Jun 30, 2024 | 57.15% |
| Mar 31, 2024 | -29.60% |
| Dec 31, 2023 | -28.98% |
| Sep 30, 2023 | -35.50% |
| Jun 30, 2023 | 44.97% |
| Mar 31, 2023 | 6.21% |
| Dec 31, 2022 | -40.98% |
| Sep 30, 2022 | -649.88% |
| Jun 30, 2022 | 65.14% |
| Mar 31, 2022 | 2.85% |
| Dec 31, 2021 | -33.88% |
| Sep 30, 2021 | -12.78% |
| Jun 30, 2021 | -43.66% |